143 related articles for article (PubMed ID: 25381132)
1. Pharmacological targeting of β-catenin in normal karyotype acute myeloid leukemia blasts.
Griffiths EA; Golding MC; Srivastava P; Povinelli BJ; James SR; Ford LA; Wetzler M; Wang ES; Nemeth MJ
Haematologica; 2015 Feb; 100(2):e49-52. PubMed ID: 25381132
[No Abstract] [Full Text] [Related]
2. Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia.
Alachkar H; Santhanam R; Harb JG; Lucas DM; Oaks JJ; Hickey CJ; Pan L; Kinghorn AD; Caligiuri MA; Perrotti D; Byrd JC; Garzon R; Grever MR; Marcucci G
J Hematol Oncol; 2013 Mar; 6():21. PubMed ID: 23497456
[TBL] [Abstract][Full Text] [Related]
3. MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia.
Sanjiv K; Calderón-Montaño JM; Pham TM; Erkers T; Tsuber V; Almlöf I; Höglund A; Heshmati Y; Seashore-Ludlow B; Nagesh Danda A; Gad H; Wiita E; Göktürk C; Rasti A; Friedrich S; Centio A; Estruch M; Våtsveen TK; Struyf N; Visnes T; Scobie M; Koolmeister T; Henriksson M; Wallner O; Sandvall T; Lehmann S; Theilgaard-Mönch K; Garnett MJ; Östling P; Walfridsson J; Helleday T; Warpman Berglund U
Cancer Res; 2021 Nov; 81(22):5733-5744. PubMed ID: 34593524
[TBL] [Abstract][Full Text] [Related]
4. Cup-like acute myeloid leukemia: new disease or artificial phenomenon?
Kroschinsky FP; Schäkel U; Fischer R; Mohr B; Oelschlaegel U; Repp R; Schaich M; Soucek S; Baretton G; Ehninger G; Thiede C;
Haematologica; 2008 Feb; 93(2):283-6. PubMed ID: 18223289
[TBL] [Abstract][Full Text] [Related]
5. 5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts.
Dembitz V; Lalic H; Kodvanj I; Tomic B; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
BMC Cancer; 2020 Nov; 20(1):1090. PubMed ID: 33176741
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts.
Reis B; Jukofsky L; Chen G; Martinelli G; Zhong H; So WV; Dickinson MJ; Drummond M; Assouline S; Hashemyan M; Theron M; Blotner S; Lee JH; Kasner M; Yoon SS; Rueger R; Seiter K; Middleton SA; Kelly KR; Vey N; Yee K; Nichols G; Chen LC; Pierceall WE
Haematologica; 2016 May; 101(5):e185-8. PubMed ID: 26869629
[No Abstract] [Full Text] [Related]
7. Combined inhibition of β-catenin and Bcr-Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo.
Zhou H; Mak PY; Mu H; Mak DH; Zeng Z; Cortes J; Liu Q; Andreeff M; Carter BZ
Leukemia; 2017 Oct; 31(10):2065-2074. PubMed ID: 28321124
[TBL] [Abstract][Full Text] [Related]
8. Re-induction therapy in adult patients with acute myeloid leukemia with ≤20 % blasts: A retrospective cohort study.
Kannan KK; Vellanki P; Isom S; Tawfik B; Winter A; Klepin HD; Ellis LR; Bhave RR; Howard D; Manuel M; Dralle S; Lyerly S; Powell BL; Pardee TS
Leuk Res; 2021 Dec; 111():106731. PubMed ID: 34695644
[No Abstract] [Full Text] [Related]
9. Cell signaling in putative leukemic stem cells and blast population in acute myeloid leukemia.
Garg S; Shanmukhaiah C; Ghosh K; Madkaikar M
Leuk Lymphoma; 2016 Sep; 57(9):2195-8. PubMed ID: 26700494
[No Abstract] [Full Text] [Related]
10. PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogene.
Guo Z; Wang A; Zhang W; Levit M; Gao Q; Barberis C; Tabart M; Zhang J; Hoffmann D; Wiederschain D; Rocnik J; Sun F; Murtie J; Lengauer C; Gross S; Zhang B; Cheng H; Patel V; Schio L; Adrian F; Dorsch M; Garcia-Echeverria C; Huang SM
Blood; 2014 Sep; 124(11):1777-89. PubMed ID: 25006129
[TBL] [Abstract][Full Text] [Related]
11. Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function.
Lim S; Saw TY; Zhang M; Janes MR; Nacro K; Hill J; Lim AQ; Chang CT; Fruman DA; Rizzieri DA; Tan SY; Fan H; Chuah CT; Ong ST
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):E2298-307. PubMed ID: 23737503
[TBL] [Abstract][Full Text] [Related]
12. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
[TBL] [Abstract][Full Text] [Related]
13. Podocalyxin is expressed in normal and leukemic monocytes.
Riccioni R; Calzolari A; Biffoni M; Senese M; Riti V; Petrucci E; Pasquini L; Cedrone M; Lo-Coco F; Diverio D; Foà R; Peschle C; Testa U
Blood Cells Mol Dis; 2006; 37(3):218-25. PubMed ID: 17059890
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD200 on AML blasts directly suppresses memory T-cell function.
Coles SJ; Hills RK; Wang EC; Burnett AK; Man S; Darley RL; Tonks A
Leukemia; 2012 Sep; 26(9):2148-51. PubMed ID: 22430635
[No Abstract] [Full Text] [Related]
15. Erythrophagocytosis by blasts in acute myeloid leukaemia harbouring the BCR-ABL1 fusion gene.
Murayama H; Matsushita H; Obayashi Y; Ando K
Br J Haematol; 2014 Dec; 167(5):586. PubMed ID: 25256906
[No Abstract] [Full Text] [Related]
16. Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models.
Dourado KMC; Baik J; Oliveira VKP; Beltrame M; Yamamoto A; Theuer CP; Figueiredo CAV; Verneris MR; Perlingeiro RCR
Blood; 2017 May; 129(18):2526-2536. PubMed ID: 28351936
[TBL] [Abstract][Full Text] [Related]
17. Robust in vivo differentiation of t(8;21)-positive acute myeloid leukemia blasts to neutrophilic granulocytes induced by treatment with dasatinib.
Chevalier N; Solari ML; Becker H; Pantic M; Gärtner F; Maul-Pavicic A; Hübner J; Wäsch R; Schmitt-Gräff A; Lübbert M
Leukemia; 2010 Oct; 24(10):1779-81. PubMed ID: 20811401
[No Abstract] [Full Text] [Related]
18. Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy.
Chen X; Newell LF; Xie H; Walter RB; Pagel JM; Sandhu VK; Becker PS; Hendrie PC; Abkowitz JL; Appelbaum FR; Estey EH
Leukemia; 2015 Aug; 29(8):1779-80. PubMed ID: 25650090
[No Abstract] [Full Text] [Related]
19. Expression of pSTAT5 predicts FLT3 internal tandem duplications in acute myeloid leukemia.
Obermann EC; Arber C; Jotterand M; Tichelli A; Hirschmann P; Tzankov A
Ann Hematol; 2010 Jul; 89(7):663-9. PubMed ID: 20066533
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation.
Gandillet A; Park S; Lassailly F; Griessinger E; Vargaftig J; Filby A; Lister TA; Bonnet D
Leukemia; 2011 May; 25(5):770-780. PubMed ID: 21339756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]